Clozapine, but not haloperidol, increases brain concentrations of neuroactive steroids in the rat

Neuropsychopharmacology

Volumn 25, Issue 4, 2001, Pages 489-497

  Barbaccia, Maria Luisa ^a   Affricano, Daniela ^a   Purdy, Robert H ^b   Maciocco, Elisabetta ^c   Spiga, Francesca ^c   Biggio, Giovanni ^c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Allopregnanolone; Allotetrahydrodeoxycorticosterone; Antipsychotic; GABA; Progesterone

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 3ALPHA,21 DIHYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; CLOZAPINE; CORTICOSTERONE; HALOPERIDOL; NEUROLEPTIC AGENT; NEUROSTEROID; PROGESTERONE; STEROID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN LEVEL; CONTROLLED STUDY; CORPUS STRIATUM; CORTICOSTERONE BLOOD LEVEL; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFECT; MALE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; STEROID BLOOD LEVEL;

ADRENALECTOMY; ANIMALS; ANTIPSYCHOTIC AGENTS; BRAIN CHEMISTRY; CLOZAPINE; DESOXYCORTICOSTERONE; HALOPERIDOL; MALE; NEUROTRANSMITTER AGENTS; ORCHIECTOMY; PROGESTERONE; RATS; RATS, SPRAGUE-DAWLEY; STEROIDS;

EID: 0034844443     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(01)00254-8     Document Type: Article

References (56)

1. Development of tolerance to the stimulatory effect of neuroleptic butyrophenones on pituitary-adrenal activity in rats
2. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics
3. A receptor function after acute stress
4. Isoniazid-induced inhibition of GABAergic transmission enhances neurosteroid content in the rat brain
5. The effects of inhibitors of GABAergic transmission and stress on brain and plasma allopregnanolone concentrations
6. A receptor binding in superficial layers of cingulate cortex in schizophrenics
7. A receptor binding on neurons of the prefrontal cortex in schizophrenic subjects
8. New insights into the biology of schizophrenia through the mode of action of clozapine
9. Interaction between GABAergic neurotransmission and rat hypothalamic corticotropin-releasing hormone secretion in vitro
10. 35S]TBPS binding in the brain of rats exposed to isoniazid, pentylenetetrazol, or stress
11. Biochemical and behavioural properties of clozapine
12. A role for 5-hydroxytryptamine in the GABA-mimetic potentiation of α-flupentixol-induced catalepsy in the rat
13. Localized increase of GABA levels in brain areas of the rat and inhibition of the plasma LH rise following orchidectomy
14. Clozapine-induced electroencephalogram changes as a function of clozapine serum levels
15. A receptor complex: The pharmacological and therapeutic potential of epalons
16. Extrapyramidal symptoms during long-term treatment with antipsychotics: Special focus on clozapine and D1 and D2 dopamine antagonists
17. Haloperidol. Plasma monitoring and hormonal effects of treatment
18. Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes
19. Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis
20. Oral movements induced by interference with nigral GABA neurotransmission: Relationship to tardive dyskinesias
21. Neuroleptic intolerance
22. Seizures and schizophrenia
23. A decrease of reelin as a putative vulnerability factor in schizophrenia
24. 2-adrenoceptor antagonism in the anticataleptic properties of the atypical neuroleptic agent, clozapine in the rat
25. The neurosteroid 3α-hydroxy-5α-pregnan-20-one induces catalepsy in mice
26. Subtype specificity of γ-aminobutyric acid type A receptor antagonism by clozapine
27. A receptor function
28. Endocrine and receptor pharmacology of serotonergic anxiolytics, antipsychotics, and antidepressants
29. A receptor
30. The turnover rate of γ-aminobutyric acid in the nuclei of the telencephalon: Implications for the pharmacology of antipsychotics and minor tranquilizers
31. Olanzapine increases allopregnanolone in the rat cerebral cortex
32. Clozapine does activate nigrostriatal dopamine neurons in unanesthetized rats
33. Clozapine inhibits synaptic transmission at GABAergic synapses established by ventral tegmental area neurones in culture
34. Injection of GABA antagonist into the mesopontine reticular formation abolishes haloperidol-induced catalepsy
35. Haloperidol increases plasma betaendorphin-like immunoreactivity and cortisol in normal human males
36. The role of GABA mechanisms in the globus pallidus in mediating catalepsy, stereotypy, and locomotor activity
37. Clozapine-related seizures: Experience with 5,269 patients
38. Neuroactive steroids
39. A receptor agonist muscimol
40. A receptors
41. Synthesis, metabolism, and pharmacological activity of 3α-hydroxy-steroids which potentiate GABA-receptor-mediated chloride ion uptake in rat cerebral cortical synaptoneurosomes
42. Differential effects of neuroleptic agents on hepatic cytochrome P450 isozymes in the male rat
43. Neurosteroids: Biosynthesis and function
44. Modulation of neurosteroid synthesis/accumulation by L-ascorbic acid in rat brain tissue: Inhibition by selected serotonin antagonists
45. Assessment of neuroleptic-like properties of progesterone
46. Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4
47. Suppression of haloperidol-induced oral dyskinesias in rats by vigabatrin
48. Clozapine-induced seizures and EEG abnormalities in ambulatory psychiatric patients
49. Brain γ-aminobutyric acid abnormality in tardive dyskinesia. Reduction in cerebrospinal fluid GABA levels and therapeutic response to GABA agonist treatment
50. Clonazepam treatment of tardive dyskinesia: A practical GABA mimetic strategy
51. Distribution of glutamate decarboxylase65 immunoreactive puncta on pyramidal and nonpyramidal neurons in hippocampus of schizophrenic brain
52. Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography
53. 35S]TBPS binding to cerebral cortical and to pituitary membranes: Correlation with inhibition of prolactin release
54. The effects of chronic haloperidol administration on GABA-immunoreactive axon terminals in rat medial prefrontal cortex
55. Time required for initial improvement during clozapine treatment of refractory schizophrenia
56. A subclass of prefrontal γ-aminobutyric acid axon terminals are selectively altered in schizophrenia